Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Beauty Health (SKIN) EBITDA (2020 - 2025)

Beauty Health (SKIN) has disclosed EBITDA for 6 consecutive years, with -$7.8 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 42.8% to -$7.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.0 million through Dec 2025, up 87.88% year-over-year, with the annual reading at -$4.0 million for FY2025, 87.88% up from the prior year.
  • EBITDA for Q4 2025 was -$7.8 million at Beauty Health, up from -$10.6 million in the prior quarter.
  • The five-year high for EBITDA was $31.3 million in Q1 2022, with the low at -$216.7 million in Q3 2021.
  • Average EBITDA over 5 years is -$23.6 million, with a median of -$7.6 million recorded in 2023.
  • The sharpest move saw EBITDA skyrocketed 5298.24% in 2022, then crashed 4262.9% in 2023.
  • Over 5 years, EBITDA stood at -$20.6 million in 2021, then soared by 142.27% to $8.7 million in 2022, then crashed by 184.06% to -$7.3 million in 2023, then plummeted by 84.97% to -$13.6 million in 2024, then skyrocketed by 42.8% to -$7.8 million in 2025.
  • According to Business Quant data, EBITDA over the past three periods came in at -$7.8 million, -$10.6 million, and $23.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.